Senores Pharmaceuticals Shares Fall 3% as Q2 Profit Rises 22%, Revenue 25%
Senores Pharmaceuticals shares fell 3% despite increases in quarterly profit and revenue. The body says results were for the quarter ended in September 2026.
Senores Pharmaceuticals shares are under pressure after the company reported its results. In the quarter that ended in September, 2026, the pharma company recorded strong number with a rise in profit, revenue and profitability.The Ahmedabad-based pharmaceutical company’s net profit rose 22.3% year…